Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Talphera, Inc.
13G
TLPH · 00444T209
|
7.9% |
9/12/2025
Event 9/10/2025
|
|||
| Rock Springs Capital Management LP | 7.9% | ||||
| Rock Springs Capital LLC | 7.9% | ||||
| Rock Springs Capital Master Fund LP | 6.2% | ||||
| Mark Bussard | 7.9% | ||||
| Kris Jenner | 7.9% | ||||
|
Inozyme Pharma, Inc.
13G/A
Amendment 3
INZY · 45790W108
|
0% |
8/13/2025
Event 6/30/2025
|
|||
| Rock Springs Capital Management LP | 0% | ||||
| Rock Springs Capital LLC | 0% | ||||
| Rock Springs Capital Master Fund LP | 0% | ||||
| Mark Bussard | 0% | ||||
| Kris Jenner | 0% | ||||
|
Spruce Biosciences, Inc.
13G/A
Amendment 5
SPRB · 85209E109
|
0% |
8/13/2025
Event 7/3/2025
|
|||
| Rock Springs Capital Management LP | 0% | ||||
| Rock Springs Capital LLC | 0% | ||||
| Rock Springs Capital Master Fund LP | 0% | ||||
| Mark Bussard | 0% | ||||
| Kris Jenner | 0% | ||||
|
Xilio Therapeutics, Inc.
13G/A
Amendment 3
XLO · 98422T100
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Rock Springs Capital Management LP | 0% | ||||
| Rock Springs Capital LLC | 0% | ||||
| Rock Springs Capital Master Fund LP | 0% | ||||
| Mark Bussard | 0% | ||||
| Kris Jenner | 0% | ||||
|
Travere Therapeutics, Inc.
13G/A
Amendment 2
TVTX · 89422G107
|
3.3% |
5/15/2025
Event 3/31/2025
|
|||
| Rock Springs Capital Management LP | 3.3% | ||||
| Rock Springs Capital LLC | 3.3% | ||||
| Rock Springs Capital Master Fund LP | 2.6% | ||||
| Mark Bussard | 3.3% | ||||
| Kris Jenner | 3.3% | ||||
|
Mereo Biopharma Group PLC
13G/A
Amendment 5
MREO · 589492107
|
4.2% |
5/15/2025
Event 3/31/2025
|
|||
| Rock Springs Capital Management LP | 4.2% | ||||
| Rock Springs Capital LLC | 4.2% | ||||
| Rock Springs Capital Master Fund LP | 3.2% | ||||
| Mark Bussard | 4.2% | ||||
| Kris Jenner | 4.2% | ||||
|
Aclaris Therapeutics, Inc.
13G/A
Amendment 1
ACRS · 00461U105
|
4.7% |
5/15/2025
Event 3/31/2025
|
|||
| Rock Springs Capital Management LP | 4.7% | ||||
| Rock Springs Capital LLC | 4.7% | ||||
| Rock Springs Capital Master Fund LP | 0% | ||||
| Mark Bussard | 4.7% | ||||
| Kris Jenner | 4.7% | ||||
|
Travere Therapeutics, Inc.
13G/A
Amendment 1
TVTX · 89422G107
|
5.7% |
2/14/2025
Event 12/31/2024
|
|||
| Rock Springs Capital Management LP | 5.7% | ||||
| Rock Springs Capital LLC | 5.7% | ||||
| Rock Springs Capital Master Fund LP | 4.8% | ||||
| Mark Bussard | 5.7% | ||||
| Kris Jenner | 5.7% | ||||